Activated Charcoal Decreases the Risk of QT Prolongation After Citalopram Overdose

Annals of Emergency Medicine

Volumn 50, Issue 5, 2007, Pages

  Isbister, Geoffrey K ^a,b,c   Friberg, Lena E ^b,d   Stokes, Barrie ^c   Buckley, Nicholas A ^e   Lee, Christopher ^e   Gunja, Naren ^f,g   Brown, Simon G ^h   MacDonald, Ellen ^h   Graudins, Andis ⁱ   Holdgate, Anna ^g   Duffull, Stephen B ^b,j  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d UPPSALA UNIVERSITY   (Sweden)

^e AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^f WESTMEAD HOSPITAL   (Australia)

^g LIVERPOOL HOSPITAL   (Australia)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ PRINCE OF WALES HOSPITAL   (Australia)

^j UNIVERSITY OF OTAGO   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; CITALOPRAM;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DRUG OVERDOSE; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROBABILITY; QT PROLONGATION; SEX DIFFERENCE; SINGLE DRUG DOSE; TORSADE DES POINTES;

ADULT; CHARCOAL; CITALOPRAM; DATABASES, FACTUAL; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MULTICENTER STUDIES; OVERDOSE; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS;

EID: 35349011020     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2007.03.009     Document Type: Article

References (16)

1. Isbister G.K., Bowe S.J., Dawson A., et al. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 42 (2004) 277-285
2. Personne M., Sjöberg G., and Persson H. Citalopram overdose: review of cases treated in Swedish hospitals. J Toxicol Clin Toxicol 35 (1997) 237-240
3. Meuleman C., Jourdain P., Bellorini M., et al. Citalopram and torsades de pointes. A case report. Arch Mal Coeur Vaiss 94 (2001) 1021-1024
4. Tarabar A.F., Hoffman R.S., and Nelson L.S. Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest. [abstract]. J Toxicol Clin Toxicol 41 (2003) 676
5. Friberg L.E., Isbister G.K., Hackett L.P., et al. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach. J Pharmacokinet Pharmacodyn 32 (2005) 571-605
6. Friberg L.E., Isbister G.K., and Duffull S.B. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br J Clin Pharmacol 61 (2006) 177-190
7. Sheiner L.B. Learning versus confirming in clinical drug development. Clin Pharmacol Ther 61 (1997) 275-291
8. Food and Drug Administration. The FDA Modernization Act. Available at http://www.fda.gov/cder/guidance/105-115.htm. Accessed April 12, 2007.
9. Malik M., Farbom P., Batchvarov V., et al. Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval. Heart 87 (2002) 220-228
10. Fossa A.A., Wisialowski T., Magnano A., et al. Dynamic beat-to-beat modeling of the QT-RR interval relationship: analysis of QT prolongation during alterations of autonomic state versus human ether a-go-go-related gene inhibition. J Pharmacol Exp Ther 312 (2005) 1-11
11. Isbister G.K., Friberg L.E., and Duffull S.B. Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose. Intensive Care Med 32 (2006) 1060-1065
12. Cooper G.M., Le Couteur D.G., Richardson D., et al. A randomised controlled trial of activated charcoal for the routine management of oral drug overdose. J Toxicol Clin Toxicol 40 (2002) 313
13. Bond G.R. The role of activated charcoal and gastric emptying in gastrointestinal decontamination: a state-of-the-art review. Ann Emerg Med 39 (2002) 273-286
14. Chyka P.A., Seger D., Krenzelok E.P., et al. Position paper: single-dose activated charcoal. Clin Toxicol (Phila) 43 (2005) 61-87
15. Isbister G.K., Dawson A.H., and Whyte I.M. Feasibility of prehospital treatment with activated charcoal: who could we treat, who should we treat?. Emerg Med J 20 (2003) 375-378
16. Chan A., Isbister G.K., Kirkpatrick C.M., et al. Drug-induced QT prolongation and torsades de pointes: An evaluation of a QT diagram. QJ Med (2007) (in press)